Fluvoxamine is an antidepressant which functions as a selective serotonin reuptake inhibitor (SSRI). Fluvoxamine was first approved by the U.S. Food and Drug Administration (FDA) in 1993 for the treatment of obsessive compulsive disorder (OCD). Fluvoxamine CR (controlled release) is approved to treat social anxiety disorder. Fluvoxamine is also prescribed to treat major depressive disorder (MDD) and anxiety disorders, such as generalized anxiety disorder (GAD), panic disorder, and post-traumatic stress disorder (PTSD).

Application:
Fluvoxamine maleate tablets are suitable for the treatment of depression and related symptoms, obsessive-compulsive symptoms.
Fluvoxamine maleate tablets have a good effect on the treatment of depression, it is recommended that patients take drugs on time and in quantity.
Fluvoxamine maleate is a thin film coating, white or white after removing the coating. It regulates the concentration of serotonin through the antagonism of 5HT4- receptor and inhibition of selective serotonin reuptake, thus it is effectively used in the treatment of depression and major depressive disorders.

Packing and storage:
In 25kg, 50kg, 1000kg net bags, store at a cool, dry and well ventilated place.

Hebei Kunsui Technology Co., Ltd. specializes in exporting high quality Pharmaceutical raw materials,  plant extract, pesticide raw materials  and Chemical raw materials. Our products are produced on the basis of best technical team, advanced equipment, high qualified management which meet the requirements of security and environmental protection. We earned customer trust and created a good reputation during these years.  We will provide the most comprehensive products and service to you! looking forward to your cooperation.